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Abstract The development of atherosclerosis (AS) is a
multifactorial process in which elevated plasma cholesterol
levels play a central role. As a new class of players involved
in AS, the regulation and function of microRNAs (miR) in
response to AS remain poorly understood. This study ana-
lyzed the effects of miR-1 (antagomir and mimic) on endo-
thelial permeability and myosin light chain kinase (MLCK)
expression and activity in the artery wall of apoE knock-out
mice after feeding them a high-cholesterol diet. Further, we
tested to determine whether that effects are involved in ERK
phosphorylation. Here, we show that a high-cholesterol diet
induces a significant decrease of miR-1 expression. Histo-
pathologic examination demonstrated that miR-1 antagomir
enhances endothelial permeability induced by high cholesterol
and miR-1 mimic attenuated endothelial barrier dysfunction.
Consistent with endothelial permeability, Western blotting,
qPCR, and c-32P-ATP phosphate incorporation showed that
MLCK expression and activity were further increased in miR-
1 antagomir-treated mice and decreased in miR-1 mimic-
treated mice compared with those of mice receiving control
miR. Further mechanistic studies showed that high-choles-
terol-induced extracellular signal regulated kinase (ERK)
activation was enhanced by miR-1 antagomir and attenuated
by miR-1 mimic. Collectively, those results indicate that miR-
1 contributes to endothelial barrier function via mechanisms
involving not only MLCK expression and activity but also
ERK phosphorylation.
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Introduction
Atherosclerosis (AS) is a pathological multifactorial pro-
cess, which very often starts with endothelial dysfunction
and at later stages results in the deposition of cholesterol
and other substances that progressively accumulate within
arteries, finally leading to the formation of plaques [1].
High plasma cholesterol is associated with the develop-
ment of AS. It has been demonstrated that cholesterol may
increase the endothelial permeability [2, 3]. However, the
available data on the structural aspects of endothelial per-
meability in the arteries are limited.
Endothelial dysfunctions are key events in the patho-
genesis of AS. Myosin light chain kinase (MLCK) has
been shown to contribute to vascular inflammation by
altering endothelial barrier function. Several laboratories
have demonstrated the central importance of MLCK in
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regulating the contractile state of the endothelial cells and
in modulating endothelial cells’ barrier function [4–6].
MLCK, which transfers the c-phosphate from ATP to
myosin, is essential for endothelial cell contraction [7, 8].
In endothelial cells, actin-myosin contraction is mainly
mediated by MLCK-catalyzed myosin light chain (MLC)
phosphorylation. The phosphorylation condition of MLC
affects the permeability of cultured endothelial cells and
intact venular endothelium [9–11].
Recent studies have uncovered important and unex-
pected roles for a family of small regulatory RNA mole-
cules, known as microRNAs (miR; miRNAs) in the
regulation of diverse aspects of cardiovascular diseases.
miRs are a class of small non-coding RNAs (20–24 nucle-
otides), which primarily bind to the 30 untranslated region of
target mRNA and negatively regulate gene expression at the
post-transcriptional level [12]. miRs are involved in a wide
range of pathophysiological cellular processes including
development, differentiation, growth, metabolism, survival/
death, and tumor formation [13–15]. Aberrant expression of
miRs has been linked to a number of cardiovascular path-
ological conditions, including AS. As such, miRs have been
suggested as novel therapeutic targets for cardiovascular
diseases [16–18]. Previous studies have demonstrated that
miR-1 is associated with cardiac hypertrophy and heart
failure [19]. However, it remains to be determined whether
miR-1 plays a role in AS.
It has been well established that diet-induced AS can
cause an increase in the permeability of the arterial endo-
thelium to lipoproteins [20]. However, whether miR-1
would affect endothelial permeability in high-cholesterol
diet mice has not been investigated. In this study, we report
that mice fed a high-cholesterol diet plus miR-1(antagomir
and mimic) showed marked differences in endothelial
permeability compared to mice fed a high-cholesterol diet,




The following reagents were purchased: Sulfo-NHS-LC-
Biotin from Pierce Chemical Co.(Rockford, IL, USA);
anti-MLCK monoclonal antibody form Sigma Co.(Saint
Louis, MI, USA); c-32P-ATP from Yahui Biomedical
Engineering Co. (Beijing, China); and miRNA oligonu-
cleotide from QIAGEN Co. (Shanghai, China). All other
chemicals used were of the purest commercially available
grade. Calmodulin and myosin regulatory light chain were
the gifts from Dr. Zhi at University of the Texas South-
western Medical Center, USA.
Animal experimental procedures
All experiments were approved by the Institutional Animal Care
and Use Committee of Anhui Medical University. apoE-/-
mice (from the Institute of Basic Medical Sciences of Peking
Union Medical College) were weaned at 4 weeks of age, at
which point mice were either placed on standard diet (control) or
a high-fat diet(standard diet plus 2 % cholesterol and 5 % lard
oil) for 16 weeks. At 12 weeks, some of the control and high-fat
mice were sacrificed for miR-1 level detection and some more of
the control and high-fat diet mice randomized into 4 groups:
control (standard diet), control miR oligonucleotide (high-fat
diet), miR-1 antagomir oligonucleotide (high-fat diet), and miR-
1 mimic oligonucleotide (high-fat diet). Mice received 2 sub-
cutaneous injections of 10 mg/kg miR-1 antagomir, miR-1
mimic, or control miR in the first week, spaced 2 days apart, and
weekly injections of 10 mg/kg miR-1 antagomir, mimic, or
control miR thereafter for 4 weeks. At sacrifice, the mice were
anesthetized with isoflurane and exsanguinated by cardiac
puncture. The mice were perfused with PBS, followed by 10 %
sucrose in PBS. A portion of the aorta was embedded in optimal
cutting temperature compound (OCT) medium and frozen
immediately, and the remaining aorta was snap frozen under
liquid nitrogen and stored at -80 C.
MiR-1 expression assay
Total RNA was extracted from the aorta of different groups
using Total RNA Isolation Reagent (TRIzol reagent,
Invitrogen). MiR-1 expression was determined using the
miRNA plate assay kit (Signosis, Inc.,) according to the
manufacturer’s instructions. For normalized RNA content,
the U6 snRNA was the internal control.
Permeability assay
The permeability assay of using the surface biotinylation
technique was performed as described by Zhu et al. [20]
with some modifications for the aorta intima. The aorta
canals were filled with freshly made 1 mg/ml Sulfo-NHS-
LC-Biotin in HBS (HBS containing 1 mM CaCl2 and 1 mM
MgCl2) for 30 min at room temperature. The aortas were
rinsed with PBS and embedded in OCT and cryosectioned.
10-lm frozen sections were incubated in blocking buffer
(1 % fish skin gelatin and 1 % BSA in PBS) for at least 5 h.
After washing three times with blocking buffer, sections
were then incubated with X-Rhodamine Isothiocyanate
(XRITC) avidin and examined by fluorescence microscopy.
MLCK mRNA assay
Real-time PCR was used—Total RNA was extracted from
the aorta of different groups using the TRIzol reagent
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(Invitrogen) following the manufacturer’s instructions.
Real-time PCR for mice MLCK and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) mRNA was performed.
The primers for MLCK and GAPDH were described previ-
ously (10).
Western blot analysis
The aortas were washed three times in PBS and then lysed in
RIPA buffer (1 % Nonidet P-40, 1 % sodium deoxycholate,
0.1 % SDS, 150 mM NaCl, 10 mM sodium phosphate buffer
pH 7.2, 2 mM EDTA, 10 mg/ml aprotinin, 10 mg/ml leu-
peptin, 2 mM PMSF, 2 mM sodium orthovanadate, 10 mM
sodium pyrophosphate, and 20 mM sodium fluoride). The
lysates were centrifuged at 15,0009g for 30 min at 4 C. The
total protein concentration of each sample was measured
using the MicroBCA Protein Assay Reagent Kit (Pierce,
Rockford, IL, USA). The same amount of lysate from each
line in SDS sample buffer was electrophoresed with 10 %
SDS-polyacrylamide gel and electroblotted onto a PVDF
membrane, which was then blocked with 5 % fat-free milk in
PBST (PBS, 01 % Tween 20) for 1 h at room temperature.
Monoclonal antibody (1:1,000 dilution) was incubated
overnight at 4 C, followed by incubation with 1:2000
diluted HRP-conjugated goat antibody against rabbit IgG,
and stained with enhanced chemiluminescence reagent
(Pierce, Rockford, IL, USA). Densitometric scanning of the
exposed X-ray film was used for semi-quantitative mea-
surement of the protein bands. Three independent experi-
ments were performed and the results were reproducible.
Assay of MLCK activity
The activity of MLCK was measured by rates of c-32P-ATP
incorporation into MLC. The maximal activity was deter-
mined in the reaction buffer containing 50 mM MOPS,
10 mM magnesium acetate, 1 mM DTT, 0.3 mM CaCl2, 1
M c-32P-ATP (200–300 cpm/pmol), 1.2 lM CaM, 25 lmol/
l myosin regulatory light chain, and diluted MLCK at room
temperature. MLCK was freshly diluted in 10 mM MOPS,
1 mM DTT, and 0.1 % BSA, added to the reaction mixture,
and samples were incubated for 10 min at 30 C. The
reaction was terminated by filtering through Whatman
paper. Filters were added to scintillation fluid and placed in a
scintillation counter. Blanks were samples run without
substrate.
Statistical analysis
The data are expressed as the mean ± SD. A comparison
among each group was performed by one-way analysis of
variance followed by the Neuman–Keuls test to evaluate
the statistical significance between two groups. P value of
\0.05 was considered to be statistically significant.
Results
MiR-1 treatment influences miR-1 expression
in the aorta
To assess the effects of miR-1 in a model of established AS,
apoE-/- mice were first fed a high-cholesterol diet for
12 weeks, then injected subcutaneously with 10 mg/kg of
miR-1 antagomir, mimic, or control miR oligonucleotides.
To maximize miR delivery, mice were injected twice during
the first week, then once weekly thereafter, for a total of
4 weeks. First, we measured the expression of miR-1 in the
aorta of the mice. Levels of miR-1 detected by quantitative
PCR were decreased in the high-cholesterol diet-fed mice
compared with those of the standard diet-fed mice (see
Fig. 1a). Further, to determine the efficacy of miR-1 treat-
ment, we measured the expression of miR-1 in the aorta of
mice after 4 weeks of treatment. Levels of miR-1 were
decreased by more than 50 % in miR-1 antagomir-treated
mice compared with those of mice receiving control miR.
Consistent with this, the expression of miR-1 in the aorta
was increased in miR-1 mimic-treated mice (see Fig. 1b).
MiR-1 treatment influences endothelial permeability
in the aorta
To demonstrate the effect of miR-1 on endothelial perme-
ability, the transport of NHSLC-biotin across the aortic intima
to the media was determined. Concentration profiles of
NHSLC-biotin were obtained as a function of the radial dis-
tance through the media of the aortic wall. Only the endo-
thelium surface of the aorta intima was biotinylated in the
normal diet mice, indicating no paracellular leakage of NHS-
LC-biotin (Fig. 2a1, b1). The aorta intimas in AS mice were
incubated with NHS-LC-biotin (Fig. 2a2, b2). The leakage of
NHS-LC-biotin into the aorta intima further increased in miR-
1 antagomir-treated mice (Fig. 2a3), compared with those of
mice receiving control miR (Fig. 2a1); consistent with this,
endothelial permeability in the aorta was attenuated in miR-1
mimic-treated mice (Fig. 2b3).
MiR-1 treatment influences MLCK expression
and activity in the aorta
With the knowledge that endothelial barrier function is
maintained by a delicate balance between tethering and con-
tractile forces that involve the cytoskeleton, we sought to
determine whether MLCK expression and activity are
involved in AS mice. Western blot and qPCR were performed
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and showed that expression of MLCK in the AS aorta was
higher than that of control in the aorta intima. MLCK
expression was further increased in miR-1 antagomir-treated
mice compared with those of mice receiving control miR.
Consistent with this, the expression of MLCK in the aorta was
decreased in miR-1 mimic-treated mice (Fig. 3a–d). Further
studies demonstrated that MLCK activity is also necessary for
high-cholesterol-induced AS. The results indicated that the
MLCK activity in the aorta was enhanced in miR-1 antago-
mir-treated mice and reduced in miR-1 mimic-treated com-
pared with those of mice receiving control miR (Fig. 3e, f).
MiR-1 treatment influences ERK phosphorylation
in the aorta
To explore whether high-cholesterol-induced ERK acti-
vation is involved in MLCK expression and activities,
phosphorylation of ERK was measured in AS mice. As
shown in Fig. 4, high-cholesterol-induced ERK activation
was enhanced by miR-1 antagomir and attenuated by
miR-1 mimic; similar results of MLCK expression and
activity were observed in high-cholesterol-induced mice,
indicating that high-cholesterol-induced MLCK expres-
sion and activity were associated with the phosphorylation
of ERK.
Discussion
The novelty of our study is that miR-1 contributed to
endothelial cell permeability, which was associated with
regulation of MLCK expression via mechanisms involving
ERK phosphorylation. Vascular endothelial cells serve as
cellular barriers to the circulating blood. There have been
Fig. 1 Total RNA was extracted from the aorta of different groups
using TRIzol reagent; MiR-1 expression was determined using the
miRNA plate assay kit; for normalized RNA content, the U6 snRNA
was the internal control. a miR-1 expression was detected in control
and AS mice. b miR-1 treatment influences miR-1 expression in the
aorta. Levels of miR-1 were detected in different miR-treated AS
mice, *P \ 0.05 significance relative to Con, #P \ 0.05 significance
relative to miR-1 antagomir
Fig. 2 miR-1 treatment influences endothelial permeability in the
aorta. After aorta intimas were incubated with NHSLC-biotin for
30 min, frozen sections were incubated with XRITC-avidin to
localize surface-bound biotin. Photographs taken at 20-fold
magnification. a 1: Con ? Con miR; 2: AS ? Con miR; 3:
AS ? miR-1 antagomir; B: 1: Con ? Con miR; 2: AS ? Con miR;
3: AS ? miR-1 mimic; *P \ 0.05 significance relative to Con,
#P \ 0.05 significance relative to AS ? Con miR
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many ultrastructural studies on arterial endothelial damage
in animals fed a high-cholesterol diet [2, 20], but few have
referred to the relationship between AS and miR-1 and its
associated permeability.
In the present study, AS was caused in the mice using a
cholesterol-rich diet. It has been demonstrated that high
plasma cholesterol is associated with the development of
AS as previously reported [2, 21, 22]. It is shown that the
permeability of the arterial wall and the expression of
MLCK increased after the mice were fed cholesterol for
12 weeks. MiR-1 mimic attenuated the permeability and
MLCK expression. The results also indicated that the
MLCK activity in the aorta was enhanced in miR-1
antagomir-treated mice and reduced in miR-1 mimic-trea-
ted compared with those of mice receiving control miR.
From those results, it is hypothesized that the change of
integrity of the arterial wall may be associated with the
miR-1 and MLCK expression and activity.
The functions of various miRs and their involvement in
biologic processes have been identified in animal models or
various cultured cells. The expression profiles of circulating
miRs with cardiovascular diseases have been extensively
studied, and it was found that miR-21, -34a, -146a, -146b-
5p, and -210 were expressed at significant levels in AS [23,
24].Unfortunately, whether miR-1 would affect endothelial
permeability in high-cholesterol diet mice has not been
investigated and the involvement of miR-1 in high-choles-
terol diet mice has received little attention. Our studies
showed that MLCK expression and activity were further
increased in miR-1 antagomir-treated mice and decreased in
miR-1 mimic-treated mice compared with those of mice
receiving control miR.
Fig. 3 miR-1 treatment
influences MLCK expression
and activity in the aorta.
Western blotting (a, b) and
qPCR (c, d) were performed as
described in the ‘‘Materials and
methods’’ section to detect
MLCK expression, and c-32P-
ATP phosphate incorporation
was performed to assay MLCK
activity(E and F). A,C,E:
1:Con ? Con miR; 2:
AS ? Con miR; 3: AS ? miR-
1 antagomir; B,D,F:
1:Con ? Con miR; 2:
AS ? Con miR; 3: AS ? miR-
1 mimic; *P \ 0.05 significance
relative to Con, #P \ 0.05
significance relative to
AS ? Con miR
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ERK/Mitogen-activated protein kinase (MAPK) pathway
is a key signal transduction pathway and is associated with
many inflammatory diseases [25]. This pathway is activated
by many cytokines and growth factors which are produced
under a state of stress and injury. Previous studies have
indicated that cell adhesion is mainly dependent on ERK
[26, 27]. Therefore, the development of AS may be associ-
ated with the ERK/MAPK pathway. When ERK/MAPK is
activated, these proteins rapidly translocate to the nucleus
where they combine with target genes and upregulate their
expression. In endothelial cells damaged by cholesterol,
MAPK protein will overexpress cell adhesion molecules
through the ERK/MAPK pathway [28]. This study indicated
that cholesterol significantly increases phosphorylation of
ERK in vascular endothelial cells. This study showed that
high-cholesterol-induced ERK activation was enhanced by
miR-1 antagomir and attenuated by miR-1 mimic.
In summary, the present study provides experimental
evidence supporting the contribution of the endothelial
cytoskeleton to the pathological regulation of endothelial
barrier function. MiR-1 and MLCK were suggested to play
important roles in the development of atherosclerosis.
However, the exact mechanism to induce MLCK expres-
sion was not known. This would be followed by a series of
events including activation or expression of a protein
phosphatase, phosphorylation or dephosphorylation of a
protein, activation or inhibition of its activity, and finally
affecting gene transcription. In a conclusion, MLCK
activity and expression influenced by miR-1 may be
involved in many signal transductions, which remain to be
elucidated in our future study.
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